Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Authors
Keywords
-
Journal
Viruses-Basel
Volume 6, Issue 7, Pages 2735-2761
Publisher
MDPI AG
Online
2014-07-17
DOI
10.3390/v6072735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs
- (2014) Henrike Fleige et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
- (2014) F. Krammer et al. JOURNAL OF VIROLOGY
- MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
- (2014) Annett Hessel et al. PLoS One
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
- (2013) Min-Chul Kim et al. ANTIVIRAL RESEARCH
- Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
- (2013) Caitlin E. Mullarkey et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical applications of attenuated MVA poxvirus strain
- (2013) Carmen Elena Gómez et al. Expert Review of Vaccines
- Development of universal influenza vaccines based on influenza virus M and NP genes
- (2013) M. Zheng et al. INFECTION
- Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian ‘avian-like’ H1N1 swine viruses in mice
- (2013) Maria R. Castrucci et al. Influenza and Other Respiratory Viruses
- Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
- (2013) F. Song et al. JOURNAL OF VIROLOGY
- H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain
- (2013) D. Eggink et al. JOURNAL OF VIROLOGY
- H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Human Cytotoxic T Lymphocytes Directed to Seasonal Influenza A Viruses Cross-React with the Newly Emerging H7N9 Virus
- (2013) C. E. van de Sandt et al. JOURNAL OF VIROLOGY
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Limited airborne transmission of H7N9 influenza A virus between ferrets
- (2013) Mathilde Richard et al. NATURE
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- A decade after SARS: strategies for controlling emerging coronaviruses
- (2013) Rachel L. Graham et al. NATURE REVIEWS MICROBIOLOGY
- Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
- (2013) Timothy J. Powell et al. PLoS One
- Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
- (2013) Peter H. Goff et al. PLoS One
- A common solution to group 2 influenza virus neutralization
- (2013) R. H. E. Friesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- Poxvirus vectors
- (2013) Joost H.C.M. Kreijtz et al. VACCINE
- Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
- (2013) Joseph N. Brewoo et al. VACCINE
- Transmission of influenza A/H5N1 viruses in mammals
- (2013) M. Imai et al. VIRUS RESEARCH
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
- (2013) Teresa Lambe et al. Scientific Reports
- Influenza virus hemagglutinin stalk-based antibodies and vaccines
- (2013) Florian Krammer et al. Current Opinion in Virology
- Clearance of influenza virus infections by T cells: risk of collateral damage?
- (2013) MLB Hillaire et al. Current Opinion in Virology
- DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults
- (2012) Geoffrey J. Gorse et al. Clinical and Vaccine Immunology
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
- (2012) K. Kai McKinstry et al. JOURNAL OF CLINICAL INVESTIGATION
- Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses
- (2012) M. L. B. Hillaire et al. JOURNAL OF GENERAL VIROLOGY
- Stable Antigen Is Most Effective for Eliciting CD8+T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia VirusIn Vivo
- (2012) Christopher Schliehe et al. JOURNAL OF VIROLOGY
- Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
- (2012) J. C. Krause et al. JOURNAL OF VIROLOGY
- Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
- (2012) R. Hai et al. JOURNAL OF VIROLOGY
- Pre-existing immunity against vaccine vectors - friend or foe?
- (2012) M. Saxena et al. MICROBIOLOGY-SGM
- Cross-neutralization of influenza A viruses mediated by a single antibody loop
- (2012) Damian C. Ekiert et al. NATURE
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
- (2012) Richard D. Antrobus et al. PLoS One
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity
- (2012) P. S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
- (2012) Glendie Marcelin et al. REVIEWS IN MEDICAL VIROLOGY
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
- (2012) Amy C. Boyd et al. VACCINE
- Global production capacity of seasonal influenza vaccine in 2011
- (2012) Jeffrey Partridge et al. VACCINE
- Pathogenesis of acute respiratory illness caused by human parainfluenza viruses
- (2012) Henrick Schomacker et al. Current Opinion in Virology
- Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines
- (2011) Marine L. B. Hillaire et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin
- (2011) J. C. Krause et al. JOURNAL OF VIROLOGY
- Characterization of the Human CD8+ T Cell Response following Infection with 2009 Pandemic Influenza H1N1 Virus
- (2011) M. L. B. Hillaire et al. JOURNAL OF VIROLOGY
- Infection with Seasonal Influenza Virus Elicits CD4 T Cells Specific for Genetically Conserved Epitopes That Can Be Rapidly Mobilized for Protective Immunity to Pandemic H1N1 Influenza Virus
- (2011) S. Alam et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
- (2011) Annett Hessel et al. PLoS One
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
- (2011) Glendie Marcelin et al. PLoS One
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses
- (2011) Grada M. van Bleek et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
- (2011) Peter L. Collins et al. VIRUS RESEARCH
- Influenza virus vaccines: lessons from the 2009 H1N1 pandemic
- (2011) Andrew J Broadbent et al. Current Opinion in Virology
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
- (2010) Davide Corti et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model
- (2010) J. H. C. M. Kreijtz et al. JOURNAL OF GENERAL VIROLOGY
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age‐Dependent Manner
- (2010) Glendie Marcelin et al. JOURNAL OF INFECTIOUS DISEASES
- Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice
- (2010) C. Meisinger-Henschel et al. JOURNAL OF VIROLOGY
- Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms
- (2010) J. R. Teijaro et al. JOURNAL OF VIROLOGY
- Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
- (2010) B. J. Bosch et al. JOURNAL OF VIROLOGY
- New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
- (2010) Robert H. E. Friesen et al. PLoS One
- A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
- (2010) Annett Hessel et al. PLoS One
- Protection from the 2009 H1N1 Pandemic Influenza by an Antibody from Combinatorial Survivor-Based Libraries
- (2010) Arun K. Kashyap et al. PLoS Pathogens
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
- (2009) Michael Schotsaert et al. Expert Review of Vaccines
- Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells
- (2009) Stephan Halle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression
- (2009) M. H. Lehmann et al. JOURNAL OF VIROLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
- (2009) Joost H. C. M. Kreijtz et al. PLoS One
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
- (2009) J.H.C.M. Kreijtz et al. VACCINE
- New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: Studies on growth, metabolism and virus propagation
- (2009) V. Lohr et al. VACCINE
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
- (2008) B. D. Forrest et al. Clinical and Vaccine Immunology
- Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF VIROLOGY
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
- (2008) A. K. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions
- (2008) Jutta Veits et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More